Trypanosoma cruzi is the causative agent of Chagas disease, and it is estimated that this disease affects 16-18 million persons in South America, causing around 50,000 deaths yearly (Kirchhoff 1994) . In spite of the great effort accomplished since the discovery of Chagas (1909) , no definitive treatment has been achieved against this disease. There is a large number of publications concerning the research of new products with trypanocidal activity (Stoppani 1999 ) and the study of pharmacological targets of this parasite (Werbovetz 2000) . However, the only two drugs available for clinical use are nifurtimox and benznidazole, being the production of the first one discontinued at the moment (Croft et al. 1997) . It is widely accepted that both products are effective in the acute phase of the infection, but treatment of chronic Chagas disease remains controversial, due to the fact that patients treated with these compounds are not parasitologically cured, as demonstrated by competitive PCR tests (Braga et al. 2000) . Moreover, both nifurtimox and benznidazole produce severe side effects, which often lead to an interruption of treatment (Castro & Díaz de Torranzo 1988) . In this regard, it remains an open field of investigation the search of new drugs without the undesirable side effects of the reference compounds and with the capacity to promote a true parasitological cure.
Selection of new trypanocidal compounds by classical methods implies the tedious work of microscopic counting (Martínez-Díaz et al. 2000 , Muelas-Serrano et al. 2000 . Development of new techniques to avoid the labour-intensive microscopic counting are always welcome. Buckner et al. (1996) reported an efficient method for the quantification of T. cruzi parasites in drug screening assays. T. cruzi strain CL parasites were genetically engineered to express the Escherichia coli β-galactosidase gene, lacZ. This enzyme is able to catalyse a colorimetric reaction. The amount of β-galactosidase activity is directly proportional to the number of transfected parasites (clone CL B5). The efficiency of the assay facilitates the screening of a larger number of candidate compounds against T. cruzi (Buckner et al. 1996) .
Heterogeneity in relation to biological properties is a patent feature of T. cruzi. Parasite isolates express differences in growth rates, infectivity, tissue tropism, antigenic composition, virulence and mortality in animal models, susceptibility to immune sera and chemotherapeutic drugs (Andrade et al. 1975 , Brener et al. 1976a , de Castro & Meirelles 1986 , Melo & Brener 1978 , Neal & van Bueren 1988 , Rovai et al. 1990 ). To our knowledge an intensive characterization of the clone CL B5 of T. cruzi, concerning biological parameters, has not been done. For this reason the purpose of this work is the description of features of this clone regarding growth kinetics of epimastigotes, metacyclogenesis in Grace medium, infectivity in mammalian cells grown in vitro, susceptibility to reference drugs and kinetics of mice infection. A study of such nature is important for a better understanding of this clone's behaviour, since it is being used for drug screening by research some groups worldwide (Buckner et al. 2001 ) and biological differences between parental strain and clones have been previously reported (Zingales et al. 1997a ).
MATERIALS AND METHODS
Parasites -T. cruzi clone CL B5 was kindly provided by Dr F Buckner through Instituto Conmemorativo Gorgas (Panama). (NMRI) mice were inoculated intra-peritoneally with the clone. After exsanguination, blood was cultured in glass tubes with 5 ml of LIT medium supplemented with 10% heat-inactivated foetal calf serum (FCS) . Two subcultures were performed in this medium before biological features were studied.
Growth curves -To determine growth kinetics, 5 ml of epimastigotes suspension in LIT medium + 10% FCS at two different concentrations, 10 5 and 5x10 5 par / ml, were maintained at 28ºC. The concentration of the parasites was counted in a haemocytometer chamber up to the 23rd day in culture. This assay was performed four times and average and standard deviation values were calculated.
Metacyclogenesis -Metacyclogenesis was achieved by transformation of epimastigotes in modified Grace medium (Osuna-Carrillo et al. 1979 ) supplemented with 10% FCS and haemin (Arévalo et al. 1985) . Stationary phase axenic cultures of epimastigotes were collected by centrifugation and washed in fresh Grace medium. Eight million epimastigotes/ml were seeded in 10 ml of metacyclogenesis medium. Up to 23 days culture density was determined in haemocytometer and the percentage of different morphological types was calculated after microscopic counting of Giemsa stained smears.
Infectivity to cultured mammalian cells -A non-phagocytic cell line (Vero fibroblasts) and a phagocytic one (J774 macrophages) were used to study infectivity. Vero fibroblasts were cultured in Minimum Essential Medium + 20% FCS and J774 macrophages in RPMI Medium + 20% FCS. In both cases 50,000 cells/well were seeded on sterile round coverslips placed on 24-well plates. Then trypomastigotes were added in different quantities: (A) 50,000/well, (B) 100,000/well, (C) 250,000/well and (D) 500,000/well. Culture medium was added to a final volume of 2 ml. Metacyclic trypomastigotes were allowed to invade cells for 24 h, at 37 ºC and 5% CO 2 . Coverslips were fixed and stained with May Grünwald Giemsa after 24, 48, 72, 96 and 168 h and percentage of infected cells, number of amastigotes/100 cells and number of amastigotes/infected cell were calculated by microscopic counting. Each test was run in triplicates (Mendez et al. 1997) .
In vivo infectivity -Infected blood was obtained from anaesthetised donor-mice by intra-cardiac puncture and diluted with non-infected blood yielding the desired number of bloodstream trypomastigotes. Three groups of 10 NMRI female mice were infected by intra-peritoneal injection of respectively 10 3 , 10 4 and 10 5 bloodstream trypomastigotes. The level of parasitemia was checked by counting in a Neubauer chamber the number of parasites in 5 µl of blood drawn from the tail of mice and diluted 1:10 in ammonium chloride (Barr et al. 1995) .
Susceptibility to chemotherapeutic agents -Parasite sensibility to nifurtimox or benznidazole was assayed using epimastigote cultures as previously described (Muelas-Serrano et al. 2000) . Three drug concentrations were used: 100, 10 and 1 µg/ml. Assays were performed in triplicate. Percentage of anti-epimastigote activity was calculated as follows: %EA = 100 x [1 -(no. epimastigotes/ml treated / no. epimastigotes/ml control )] Sensibility of intracellular amastigotes to reference drugs was also tested. Assays were carried out as described in Muelas-Serrano et al. (2001) . Due to the high infectivity of this clone, a mammalian cell-parasite ratio of 1:2 was used. Anti-amastigote activity was calculated as follows: %AA = 100 x [1 -(no. amastigotes/100 MØ treated / no. amastigotes/100 MØ control )]
RESULTS
Epimastigotes growth curve is shown in Fig. 1 . Using both inocula (10 5 and 5x10 5 parasites/ml) a growth peak over 14x10 6 epimastigotes/ml was reached, but this peak occurred 3 days later in experience with the lowest inoculum. Stationary phase started immediately thereafter and culture density lowered to around 2x10 6 epimastigotes/ml for another 10 days. Transformation to metacyclic forms is represented in Fig. 2 . Percentage of epimastigotes decreased up to a limit around 50%, at the same time percentage of trypomastigotes increased reaching a maximum around day 16 of 39%, and that of intermediary forms remained constant and around 5%. Tables I and II show assays of infectivity to Vero fibroblasts and J774 macrophages, respectively. For Vero cells, the number of amastigotes/infected cell increases until 96 h of incubation, thereafter new trypomastigotes are liberated and infect other host cells, thus increasing significantly the number of amastigotes/100 cells after 168 h of incubation. J774 macrophages are dramatically infected, even with infection ratio of 1:1. When infection ratio is higher than 1:2, cells are so intensively infected that they break after only 24 h of culture and free amastigotes can be observed. When using an infection ratio of 1:10, J774 macrophages are simply destroyed, thus counting is almost impossible. In the case of J774 cells, reinfection occurs earlier than for Vero cells, 96 h after first cell-parasite contact, as can be deduced by the important decrease of percentage of non-infected cells and increase in number of amastigotes/100 macrophages.
Parasitemia kinetics in NMRI mice is plotted in Fig. 3 . As it can be observed infectivity peaks occur between days 12 and 15. No animal died during the experience and parasitemia was kept relatively low, reaching a maximum of 10 5 trypomastigotes/ml of blood for the highest inoculum injected.
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DISCUSSION
CL strain presents important characteristics of T. cruzi: such as isolation from a strictly domiciliary vector, Triatoma infestans, differentiation in liquid medium, infection to cell monolayers with has preferential parasitism of heart and muscle cells. It presents defined parasitemia curves and mortality in mice, and shows a clear acute phase in accidentally infected humans being highly susceptible to drugs used clinically in Chagas disease (Zingales et al. 1997a) . For this reason clone CL Brener was selected for T. cruzi genome project (Zingales et al. 1997c ) and on the same line, a β-galactosidase clone (CL B5) was engineered for drug screening (Buckner et al. 1996) . This latter clone was described as very stable and as having in vitro growth rates as epimastigotes and as mammalian forms very similar to those of non-transfected parasites (Buckner et al. 1996) , but no further information was given about other biological parameters. From our point of view, an extensive characterization of this clone was required, since it is being frequently used for drug screening (Buckner et al. 2001) .
The growth of CL B5 epimastigotes in LIT medium shows some differences in relation to Bolivia and GM strains (Martínez Díaz et al. 2001) in the same experimental conditions. Although the peak of parasite concentration occurs at similar time for the three populations, for CL B5 it is slightly lower and the density at stationary phase is about 2 x 10 6 epimastigotes/ml, while with both strains the value of 20 x 10 6 epimastigotes/ml is maintained. Differentiation indices to metacyclic forms in Grace's medium were up to 40%. Differentiation is slow, starting after 9 days of incubation at 28ºC and reaching a peak at day 16. Percentage of metacyclic forms is similar to that of the parental strain but is reached after 16 days instead of 7-10 days (Zingales et al. 1997a) .
As other CL clones, amastigote to trypomastigote differentiation takes place at 37 ºC (Zingales et al. 1997a ), contrasting to the CL parental strain requirement of 33 ºC (Brener et al. 1976b) . Our data indicate that clone CL B5 is able to penetrate phagocytic and non-phagocytic cells efficiently when compared to other strains (Zingales et al. 1997a , Martínez-Díaz et al. 2001 . On the other hand, if phagocytic cells are to be used as host mammalian cells in drug screening assays, a cell-parasite ratio of 1:2, instead of 1:10 ) is recommended, since at higher ratios host cell destruction is observed.
In vitro assays with reference drugs, informs us that both epimastigotes and intra-cellular amastigotes are not resistant to nifurtimox and benznidazole, as occurs in the case of CL strain (Zingales et al. 1997b) .
The main biological difference observed in clone CL B5 in relation to CL strain is its lower infectivity to mice. While parental strain causes high levels of parasitemia and 100% of mortality in Balb/C mice following the i.p. inoculation of 5 x 10 3 bloodstream forms (Zingales et al. 1997b) , clone CL B5 infection produces no deaths in NMRI mice, even following an infection with 10 5 bloodstream trypomastigotes.
In spite of the low in vivo infectivity of this clone, this extensive biological characterization demonstrated that clone CL B5 has the important features required for in vitro drug screening, since it grows adequately in liquid medium as epimastigotes, it differentiates and infects different cell lines intensively and it is susceptible to reference drugs. After all, this clone has been engineered for in vitro assays, so mice infectivity is not a necessary characteristic.
